Chris Freeman - Nov 7, 2022 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Commercial Officer
Signature
/s/ John Saia, as attorney-in-fact for Chris Freeman
Stock symbol
GH
Transactions as of
Nov 7, 2022
Transactions value $
$0
Form type
4
Date filed
11/9/2022, 04:39 PM
Previous filing
Jun 17, 2022
Next filing
Jun 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH STOCK OPTION (RIGHT TO BUY) Award $0 +61.7K $0.00 61.7K Nov 7, 2022 COMMON STOCK 61.7K $47.20 Direct F1
transaction GH RESTRICTED STOCK UNITS Award $0 +30.9K $0.00 30.9K Nov 7, 2022 COMMON STOCK 30.9K $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a stock option granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on November 7, 2023 and the remaining 75% of the shares vests in equal monthly installments over the remaining three-year period thereafter.
F2 This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on November 7, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
F3 Not applicable for Restricted Stock Units.